Patient Reported Experiences and Outcomes Associated with Standard C-Section Wound Closure Versus STRATAFIX/DERMABOND PRINEO Wound Closure (CS-PREO)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorNorth York General Hospital

About this trial

The aim of the study is to compare outcomes between patients receiving standard C-section wound closure compared to a wound closure bundle that includes Stratafix sutures and Dermabond PRINEO.

Eligibility criteria

Qualifiers

Patient must be 18 years of age or older at time of recruitment

Patients opting for a planned (elective) C-Section (13-36 weeks gestation) will be eligible to consent.

Patients must have internet access and/or a smartphone in order to access the digital platform to complete the study questionnaires

Patients must speak and write in English as study questionnaires will only be provided in English

Disqualifiers

Ability to consent or use the virtual care platform (e.g., patients with intellectual disabilities)

Expectation of significant maternal complications that may affect the surgery

Patients who enroll in the study but have an unplanned emergency C-section

Trial design

Treatments tested in this trial

  • Stratafix Suture
  • DERMABOND PRINEO

Treatment groups

68 Participants
are divided into 2 treatment groups

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

North York General HospitalRecruitingM2K1E1, North York, OntarioCanadaCanada

Sponsors and collaborators

North York General Hospital

Lead sponsor

Johnson & Johnson

Collaborator